Green Cross Cell Corporation is engaged in manufacturing of anti-cancer drugs. The company operates in three business areas: Immunotherapy is engaged in developing and manufacturing anti-cancer drugs for liver cancer, brain tumor, pancreatic cancer, among others; Cord Blood Cryopreservation is engaged in cryopreservation of cord blood found in the placenta and umbilical cord which in turn used to treat incurable diseases such as childhood cancer, leukemia, and other diseases; and KGMP service is engaged in providing hi-tech production facilities used to manufacture pharmaceutical products. Green Cross Cell Corporation distributes Immuncell-LC drugs. The company is based in Seoul, South Korea. Green Cross Cell Corporation was incorporated in 1992.
Headquarters
107, Ihyeon-ro 30beon-gil Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;
Postal Code: 153769
Contact Details: Purchase the Green Cross Cell Corporation report to view the information.
Website: http://www.greencrosscell.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service